German pharmaceutical giant Bayer AG plans to save €2 billion ($2.2 billion) in organizational costs by 2026 in a bid to overcome high debts without selling any divisions. Asked about the future structure of the company and a possible split-up, Bayer’s chief executive Bill Anderson said “not now.” Nevertheless, “we will remain open to everything,” Anderson said on Tuesday during the presentation of the company’s annual figures, according to a press release. In view of the very limited room for manoeuvre, business development should first be improved and more strategic flexibility created, he s…